Products
  1. Home
  2. Products
  3. Inhibitors & Activators for IBD Research
Products
Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

EZM0414

Cat. No.: IBDI-434085

EZM0414 is a potent, selective, orally bioavailable inhibitor of SETD2 (IC50=18 nM in SETD2 biochemical assay; IC50=34 nM in cellular assay). EZM0414 can be used for the research of relapsed or refractory multiple myeloma and diffuse large B-cell lymphoma.

Size (Solid):

Product Details

Target Histone MethylTransfeRase
Molecular Weight 400.49
Appearance Solid
SMILES FC1=C2C(NC(C(N[[email protected]]3C[[email protected]](N4CCN(CC4)C(C)=O)([H])CCC3)=O)=C2)=C(C=C1)C
Purity 99.45%

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.
Copyright © Ace Therapeutics. All rights reserved.